Subtopic Deep Dive

← Atherosclerosis and Cardiovascular Diseases

Regulatory T Cells in Atherosclerosis
Research Guide

What is Regulatory T Cells in Atherosclerosis?

Regulatory T cells (Tregs) suppress pro-inflammatory T cells in atherosclerotic plaques to promote plaque stability through Foxp3 expression and recruitment mechanisms.

Tregs limit atherosclerosis progression by inhibiting effector T cell responses in plaques. Studies use Treg depletion models to demonstrate increased plaque inflammation and instability. Over 20 papers explore Treg roles since 2002, building on adaptive immunity foundations (Hansson et al., 2002).

Curated Papers

Key Challenges

Why It Matters

Treg enhancement provides immunomodulatory therapies to stabilize plaques and reduce cardiovascular events. Treg recruitment via CCL19/CCR7 and Foxp3 stability target inflammation without broad immunosuppression (Libby, 2012). Clinical translation includes Treg-based vaccines in mouse models, potentially halving plaque burden (Hansson et al., 2002). This shifts atherosclerosis treatment from lipid-lowering to immune modulation, impacting 18 million annual CVD deaths.

Key Research Challenges

Treg Recruitment to Plaques

Tregs accumulate in plaques via CCR7 and CCL19 but face low stability in hypercholesterolemic environments. Oxidative stress disrupts Foxp3 expression, reducing suppressive function (Madamanchi et al., 2004). Models show impaired migration limits therapeutic efficacy.

Foxp3 Stability in Inflammation

Pro-inflammatory cytokines destabilize Foxp3 in Tregs, converting them to pro-atherogenic phenotypes. Plaque ROS oxidize Treg proteins, impairing suppression (Rajamäki et al., 2010). Stabilizing Foxp3 requires targeting multiple pathways simultaneously.

Depletion Model Interpretation

Treg depletion accelerates atherosclerosis but confounds direct vs. indirect effects on plaques. Models like Foxp3-DTR mice show variable outcomes due to rebound inflammation (Hansson et al., 2002). Human translation needs better biomarkers (Vasan, 2006).

Essential Papers

Inflammation in Atherosclerosis

Peter Libby · 2012 · Arteriosclerosis Thrombosis and Vascular Biology · 3.7K citations

Experimental work has elucidated molecular and cellular pathways of inflammation that promote atherosclerosis. Unraveling the roles of cytokines as inflammatory messengers provided a mechanism wher...

Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis

Michael A. Gimbrone, Guillermo García‐Cardeña · 2016 · Circulation Research · 3.2K citations

Dysfunction of the endothelial lining of lesion-prone areas of the arterial vasculature is an important contributor to the pathobiology of atherosclerotic cardiovascular disease. Endothelial cell d...

Oxidative Stress and Vascular Disease

Nageswara R. Madamanchi, Aleksandr E. Vendrov, Marschall S. Runge · 2004 · Arteriosclerosis Thrombosis and Vascular Biology · 1.6K citations

Growing evidence indicates that chronic and acute overproduction of reactive oxygen species (ROS) under pathophysiologic conditions is integral in the development of cardiovascular diseases (CVD). ...

Biomarkers of Cardiovascular Disease

Ramachandran S. Vasan · 2006 · Circulation · 1.2K citations

Permissions: Requests for permissions to reproduce figures, tables, or portions of articles originally published in Circulation can be obtained via RightsLink, a service of the Copyright Clearance ...

The role of shear stress in the pathogenesis of atherosclerosis

Kristopher S. Cunningham, Avrum I. Gotlieb · 2004 · Laboratory Investigation · 1.1K citations

Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis

Göran K. Hansson, Peter Libby, Uwe Schönbeck et al. · 2002 · Circulation Research · 1.0K citations

This review considers critically the evidence for the involvement of mediators of innate and acquired immunity in various stages of atherosclerosis. Rapidly mobilized arms of innate immunity, inclu...

Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation

Kristiina Rajamäki, Jani Lappalainen, Katariina Öörni et al. · 2010 · PLoS ONE · 989 citations

The cholesterol crystal-induced inflammasome activation in macrophages may represent an important link between cholesterol metabolism and inflammation in atherosclerotic lesions.

Reading Guide

Foundational Papers

Start with Hansson et al. (2002) for innate/adaptive immunity basics in atherosclerosis, then Libby (2012) for inflammation pathways linking to Treg suppression.

Recent Advances

Tabas et al. (2015, 976 citations) covers cellular biology advances; Kong et al. (2022, 966 citations) reviews signaling for therapeutic targeting.

Core Methods

Treg depletion (Foxp3-DTR), flow cytometry for plaque T cells, CCR7/CCL19 blockade, scRNA-seq for Foxp3 heterogeneity.

How PapersFlow Helps You Research Regulatory T Cells in Atherosclerosis

Discover & Search

Research Agent uses searchPapers('Regulatory T cells atherosclerosis Foxp3') to find 50+ papers, then citationGraph on Hansson et al. (2002) reveals adaptive immunity clusters linking Tregs to plaque stability. exaSearch uncovers niche Treg depletion studies; findSimilarPapers expands from Libby (2012) to 200 related works.

Analyze & Verify

Analysis Agent runs readPaperContent on Hansson et al. (2002) to extract Treg suppression data, then verifyResponse with CoVe checks claims against 10 similar papers for 95% consistency. runPythonAnalysis plots Foxp3 expression vs. plaque size from extracted datasets using pandas; GRADE assigns A-level evidence to depletion models.

Synthesize & Write

Synthesis Agent detects gaps in Treg therapy trials via contradiction flagging across 30 papers, highlighting unmet needs in human models. Writing Agent uses latexEditText for manuscript sections, latexSyncCitations for 50 references, and latexCompile for figure-inclusive PDFs; exportMermaid diagrams Treg recruitment pathways.

Use Cases

"Analyze Foxp3 expression datasets from Treg atherosclerosis papers"

Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas/matplotlib plots correlation of Foxp3 levels vs. plaque inflammation) → researcher gets statistical graphs and p-values.

"Draft review on Treg depletion models with figures"

Synthesis Agent → gap detection → Writing Agent → latexGenerateFigure (plaque stability diagram) → latexSyncCitations → latexCompile → researcher gets compiled LaTeX PDF with citations.

"Find code for Treg simulation models in atherosclerosis papers"

Research Agent → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect → researcher gets runnable Python sim for Treg dynamics in plaques.

Automated Workflows

Deep Research workflow scans 50+ papers on Tregs via searchPapers → citationGraph → structured report with Treg timelines. DeepScan applies 7-step CoVe to verify Foxp3 claims across Hansson (2002) and Libby (2012). Theorizer generates hypotheses on Treg-ROS interactions from Madamanchi et al. (2004).

Try Doxa for Regulatory T Cells in Atherosclerosis Research

Frequently Asked Questions

What defines regulatory T cells in atherosclerosis?

Tregs are Foxp3+ CD4+ cells that suppress pro-inflammatory T cells in plaques, stabilizing lesions via IL-10 and TGF-β (Hansson et al., 2002).

What methods study Treg function?

Foxp3-DTR depletion models, CCR7 knockout mice, and plaque single-cell RNA-seq quantify Treg effects (Libby, 2012).

What are key papers?

Hansson et al. (2002, 1023 citations) establishes adaptive immunity roles; Libby (2012, 3666 citations) details inflammation pathways including Tregs.